Oncology Insights

A Catalyst Oncology Newsletter?

We’re thrilled to share with you the latest edition of Catalyst Oncology Insights! This issue is packed with?exciting updates from our experts from around the world. Learn more about our innovative offerings and where to connect with Catalyst Oncology.?

Conference Chronicles?

The ASCO Annual Meeting kicked off Catalyst Oncology’s June, followed by several other pivotal oncology conferences. Our team of experts enjoyed?their conference experiences, learning and sharing new insights and perspectives set to shape the future of oncology research.?

The ASCO conference, renowned for its cutting-edge research and collaborative spirit, did not disappoint. With over 40,000 attendees,?the brightest minds in oncology research and treatment?converged to share their latest findings.????

A highlight from ASCO was on National Cancer Survivors Day, when Catalyst Oncology, announced a collaboration with Imerman Angels,?a renowned nonprofit organization providing free, personalized one-on-one cancer support.?This partnership aims to increase the visibility of the support and resources available to cancer patients, survivors, and caregivers, ensuring no one faces cancer alone. Read the full news release. ?

This momentous occasion was further highlighted by an inspiring presentation from Jonny Imerman, the founder of Imerman Angels.?

More to come on ASCO 2024 key industry takeaways!?

Earlier this month we had the opportunity to attend the BIO International Convention, a?hub for the latest advancements in biotech, attracting over 18,500 professionals, and featuring more than 100 sessions across 18 focus areas, including AI and digital health, personalized medicine, neurology, next-generation and cell and gene therapies. ?

If you were unable to attend or would like to learn more, Meredith Manuel, Executive Director, Catalyst Oncology Consulting, provides a detailed analysis and her key insights from the event. Click to read!

Upcoming!

If you missed us, be sure to connect with us at the following upcoming conferences.?

• Meet us in Boston for the 13th annual Clinical Trials in Oncology East Coast 2024 conference July 9-10! Keya Watkins, SVP, Catalyst Oncology, chairs this two-day event focused on optimizing cancer trial operations. Be sure to join us at?11:30 a.m., July 10, where Keya will lead a pivotal panel discussion: How Your Outsourcing Strategy Will Shape the Success of Your Clinical Research in Oncology. Also, attend “Forging Strong Partnerships” at 11 a.m., July 10, featuring Kate Lai, Director, Program Management, Mythic Therapeutics, and Troy Deselms, Associate Director, Project Finance, Catalyst Clinical Research.?

• Another chance to connect is at Society for Clinical Research Sites (SCRS) 2024 in Melbourne, Australia. SCRS unites over 11,000 sites in 54 countries and focuses on advocacy, education, mentorship, and connection for the clinical research community. Our Catalyst Oncology team in Australia will be at booth #17. Connect with?Megan Collett, Pip Pattinson, & Vasilisa Skliarenko to explore how our site network can enhance your clinical trials.??

Catalyst Oncology: A Global Approach?

This month we continue the series A Global Approach where we introduce our international Catalyst Oncology team members and their passions for the work they do for our clients.?

We introduced Allan Robinson, Senior Site Activation Manager II. Allan has more than 5 years of experience in clinical research and site startup. He works to ensure that submissions to the European and UK authorities are approved, and sites are activated within the agreed timelines so patients can be treated as early as possible. Read more about Allan and how his passion for Catalyst Oncology's approach supports our clients and their studies.?

?Another integral member of our team is Alice Preston, Project Manager. She brings more than 10 years of experience and plays a vital role in overseeing clinical trials in the Asia-Pacific (APAC) region. Based in Brisbane, Australia, she prioritizes meeting sponsor expectations and required outcomes while ensuring patient safety. Learn more about Alice and Catalyst Oncology's management of clinical trials in the APAC region.?